Conditions: Ampullary Adenocarcinoma
Interventions: Drug: Folfirinox; Drug: Capox
Sponsors: Fondazione Poliambulanza Istituto Ospedaliero; Associazione Italiana per la Ricerca sul Cancro
Recruiting
Feeds
40322 items (40322 unread) in 74 feeds
Acinar Cell Carcinoma
(947 unread)
Acinic Cell Carcinoma
(353 unread)
Adenoid Cystic Carcinoma
(509 unread)
Adrenal Gland Cancer
(3507 unread)
Ampulla Of Vater
(575 unread)
Anal Cancer
(3208 unread)
Angiosarcoma
(1004 unread)
Appendix Cancer
(1264 unread)
Bile Duct Cancer
(5441 unread)
Brain and CNS
(7735 unread)
Carcinoid
(859 unread)
Endocrine/Neuroendocrine
(6661 unread)
Gall Bladder Cancer
(1824 unread)
Hemangioendothelioma
(1750 unread)
Hepatoblastoma
(545 unread)
Pancreas
(607 unread)
Phyllodes
(491 unread)
PMP and Mucinous Tumors
(396 unread)
Rhabdomyosarcoma
(1282 unread)
Sarcoma
(1364 unread)
Trial - Ampullary Carcinoma (9 unread)
-
The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer.
Posted: October 5th, 2023, 2:00am GMT
-
Surufatinib Combined With Toripalimab and AG Regiments for First-line Treatment of Unresectable or Relapsing Metastatic Ampullary Carcinoma
Posted: October 2nd, 2023, 2:00am GMT
Conditions: Ampullary Carcinoma
Interventions: Drug: Surufatinib+Toripalimab+AG
Sponsors: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not yet recruiting -
Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions
Posted: November 1st, 2022, 2:00am GMT
Conditions: Cholangiocarcinoma; Bile Duct Neoplasms
Interventions: Procedure: Single-operator cholangioscopy
Sponsors: Soonchunhyang University Hospital
Recruiting -
Study Comparing Standard of Care Chemotherapy With/ Without Sequential Cytoreductive Surgery for Patients With Metastatic Foregut Cancer and Undetectable Circulating Tumor-Deoxyribose Nucleic Acid Levels
Posted: June 18th, 2021, 2:00pm GMT
Conditions: Metastatic Cancer; Foregut Carcinoid Tumor; Gastric Adenocarcinoma; Gallbladder Adenocarcinoma; Liver Cancer; GI Cancer; GI Carcinoma; Lung Cancer
Interventions: Drug: Standard of Care Chemotherapy; Procedure: Video-Assisted Thoracic Surgery (VATS); Procedure: Lobectomy; Radiation: Consolidative Radiation; Radiation: Ablation Treatment; Procedure: Resection or Excision; Procedure: Peritonectomy; Other: Transarterial Radioembolization
Sponsors: University of Chicago
Not yet recruiting -
A Study to Assess RXC004 Efficacy in Advanced Solid Tumours After Progression on Standard of Care (SoC) Therapy (PORCUPINE2)
Posted: June 1st, 2021, 2:00pm GMT
Conditions: Advanced Solid Tumours
Interventions: Drug: RXC004; Drug: RXC004; Drug: RXC004; Biological: Denosumab; Biological: Pembrolizumab
Sponsors: Redx Pharma Plc; Merck Sharp & Dohme LLC
Active, not recruiting -
Observation of Perioperative Outcomes of Robotic Pancreaticoduodenectomy
Posted: November 21st, 2019, 3:00pm GMT
Condition: Pancreaticoduodenectomy
Intervention: Procedure: robotic pancreaticoduodenectomy
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Recruiting -
Long-term Outcomes of Endoscopic Resection (ER) of Lesions of the Duodenum and Ampulla
Posted: December 3rd, 2014, 3:00pm GMT
Condition: Adenoma, Villous
Intervention: Procedure: Endoscopic Mucosal Resection
Sponsor: Professor Michael Bourke
Recruiting -
The Cancer of the Pancreas Screening-5 CAPS5)Study
Posted: December 3rd, 2013, 3:00pm GMT
Conditions: Pancreas Cancer; Peutz-Jeghers Syndrome (PJS); Gene Mutation; Germline Mutation Carrier; Lynch Syndrome
Interventions: Drug: Secretin; Diagnostic Test: MRI; Other: Tumor marker gene test with CA19-9
Sponsors: Johns Hopkins University; ChiRhoClin, Inc.; National Cancer Institute (NCI)
Recruiting -
ADH-1, Gemcitabine Hydrochloride & Cisplatin in Treating Metastatic Pancreatic or Biliary Tract Cancer
Posted: April 5th, 2013, 2:00am GMT
Conditions: Ampulla of Vater Adenocarcinoma; Gallbladder Adenocarcinoma; Metastatic Pancreatic Adenocarcinoma; Pancreatic Adenocarcinoma; Stage III Ampulla of Vater Cancer; Stage III Intrahepatic Cholangiocarcinoma; Stage III Pancreatic Cancer; Stage IIIA Gallbladder Cancer; Stage IIIA Hilar Cholangiocarcinoma; Stage IIIB Gallbladder Cancer; Stage IIIB Hilar Cholangiocarcinoma; Stage IV Ampulla of Vater Cancer; Stage IVA Gallbladder Cancer; Stage IVA Hilar Cholangiocarcinoma; Stage IVA Intrahepatic Cholangiocarcinoma; Stage IVA Pancreatic Cancer; Stage IVB Gallbladder Cancer; Stage IVB Hilar Cholangiocarcinoma; Stage IVB Intrahepatic Cholangiocarcinoma; Stage IVB Pancreatic Cancer
Interventions: Drug: ADH-1; Drug: Cisplatin; Drug: Gemcitabine Hydrochloride; Other: Laboratory Biomarker Analysis
Sponsors: University of Nebraska; Adherex Technologies, Inc.; National Cancer Institute (NCI)
Completed